Apparatus and method for optimizing treatment using medication compliance patterns and glucose sensor
First Claim
1. A medication monitor comprising:
- a housing configured to contain medication;
a detection device integrally formed into the housing, the detection device having a sample collection device and a target agent sensor for detecting a target agent in a biological sample from a user, whereinthe target agent sensor includes a plurality of sensors, where each sensor of the plurality of sensors comprises;
a solid support to which is attached a recognition molecule that specifically binds to the target agent in the presence of the target agent but not significantly to other agents,a substance that can be enzymatically converted to glucose, andan enzyme that can catalyze the conversion of the substance to glucose in the presence of the target agent, whereineach sensor of the plurality of sensors being configured to detect a different target agent, andat least one sensor of the plurality of sensors is configured to detect Tacrolimus or a metabolite thereof;
a processor configured to correlate the user'"'"'s pattern of compliance with medication data and generate an adjusted treatment regimen upon identifying, based on an amount of glucose sensed, a pattern of misses in an initial treatment regimen; and
a communication port configured to communicate the medication data to a data network.
0 Assignments
0 Petitions
Accused Products
Abstract
Methods and apparatus monitor medication usage data for one patient or a population of patients, which can be processed to determine compliance patterns. Such methods and systems can associate, analyze, organize and present medication usage data, compliance patterns, and correlations between compliance patterns and outcomes data for electronic analysis or analysis by a caretaker. Such methods and apparatus permit analysis of compliance patterns to enable, for example, establishment or adjustment of safe and effective treatment regimens, and may include feedback systems for ensuring authenticity of medication and/or effects of medication on a patient. Such methods and apparatus also permit detection of medication in a biological sample of the patient through a medication monitor having a detection device, such as a skin-prick device, and a glucose sensor that can detect a target agent in the biological sample.
-
Citations
20 Claims
-
1. A medication monitor comprising:
-
a housing configured to contain medication; a detection device integrally formed into the housing, the detection device having a sample collection device and a target agent sensor for detecting a target agent in a biological sample from a user, wherein the target agent sensor includes a plurality of sensors, where each sensor of the plurality of sensors comprises; a solid support to which is attached a recognition molecule that specifically binds to the target agent in the presence of the target agent but not significantly to other agents, a substance that can be enzymatically converted to glucose, and an enzyme that can catalyze the conversion of the substance to glucose in the presence of the target agent, wherein each sensor of the plurality of sensors being configured to detect a different target agent, and at least one sensor of the plurality of sensors is configured to detect Tacrolimus or a metabolite thereof; a processor configured to correlate the user'"'"'s pattern of compliance with medication data and generate an adjusted treatment regimen upon identifying, based on an amount of glucose sensed, a pattern of misses in an initial treatment regimen; and a communication port configured to communicate the medication data to a data network. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17)
-
-
18. A self-contained medication monitor comprising:
-
a housing body configured to contain medication; a first detection device for detecting removal of medication from the self-contained medication monitor, the first detection device being integrally formed into the housing; a second detection device having a target agent sensor for detecting a target agent in a biological sample from a user, the second detection device being integrally formed into the housing, wherein the target agent sensor includes a plurality of sensors, where each sensor of the plurality of sensors comprises; a solid support to which is attached a recognition molecule that specifically binds to the target agent in the presence of the target agent but not significantly to other agents; a substance that can be enzymatically converted to glucose; and an enzyme that can catalyze the conversion of the substance to glucose in the presence of the target agent; a processor that produces medication usage data and medication data based on detected removal of the medication and an amount of glucose sensed and that outputs recommendations to the patient based on the medication usage data and medication data; and a display device configured to display the recommendations to the patient; wherein each sensor of the plurality of sensors being configured to detect a different target agent, and at least one sensor of the plurality of sensors is configured to detect Tacrolimus or a metabolite thereof. - View Dependent Claims (19, 20)
-
Specification